We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Latest Industry Insights
Tapping Into Information Locked in Our T Cells To Fight COVID-19
Industry Insight

Tapping Into Information Locked in Our T Cells To Fight COVID-19

T cells are an important part of our immune memory and offer a wealth of valuable information about the way our bodies perceive and respond to pathogens. Learn how this information is being harnessed and applied in the fight against COVID-19.
Why Automation Will be the Cornerstone of the Post-COVID Biology Lab
Industry Insight

Why Automation Will be the Cornerstone of the Post-COVID Biology Lab

The 21st century has seen a revolution in how we approach research. With the advent of new technologies like automation and machine/deep learning, biology is becoming a less inferential and more data-driven discipline. With scientific research delayed worldwide due to the COVID-19 pandemic, is it time to re-examine the future role of automation in biological research?
Ultra-High-Throughput Proteomics To Discover New Biomarkers To Predict COVID-19 Severity
Industry Insight

Ultra-High-Throughput Proteomics To Discover New Biomarkers To Predict COVID-19 Severity

In a study recently published in Cell Systems, a new ultra-high-throughput proteomics method was used to identify 27 blood biomarkers that distinguished COVID-19 patients with mild or severe responses. We spoke to Dr Markus Ralser to learn more about the study and how the method could potentially be used in the clinic to diagnose COVID-19 severity.
Harnessing Human Skin Models for Drug Development
Industry Insight

Harnessing Human Skin Models for Drug Development

We recently spoke with Pascal Descargues, CEO at Genoskin to learn more about the legal restrictions on animal testing and how human skin tissue can be used as an alternative.
Progress in Companion Diagnostic Development for Low-Grade Glioma
Industry Insight

Progress in Companion Diagnostic Development for Low-Grade Glioma

To learn about the benefits of accelerating turnaround times for genomic testing and the importance of partnering with pharma companies to develop companion diagnostics, Technology Networks spoke with Luca Quagliata, PhD, BCMAS, global director of medical affairs for Thermo Fisher Scientific.
The Science Behind Saliva-Based Rapid Diagnostic Testing
Industry Insight

The Science Behind Saliva-Based Rapid Diagnostic Testing

Here, Dr Pretorius examines the use of saliva, rather than blood, in rapid diagnostic tests for malaria and how this clinically informative biofluid could help to improve healthcare in the world’s poorest regions.
New RNA Extraction Strategies Help Mitigate Shortages in SARS-CoV-2 PCR Components
Industry Insight

New RNA Extraction Strategies Help Mitigate Shortages in SARS-CoV-2 PCR Components

As the world continues to battle through the pandemic, developing innovative strategies to expand the availability of extraction, and any other testing components that are facing supply issues, will be an ongoing requirement.
Exploring the Technology Behind a Blood Test for Alzheimer's Disease
Industry Insight

Exploring the Technology Behind a Blood Test for Alzheimer's Disease

Technology Networks recently spoke to Quanterix's Kevin Hrusovsky to hear more about how the company's technology is being applied in the pursuit of a biomarker for Alzheimer's disease, a progressive neurodegenerative condition for which diagnosis often occurs after the onset of symptoms.
 Breaking Down Barriers in Proteomic-Based Drug Discovery
Industry Insight

Breaking Down Barriers in Proteomic-Based Drug Discovery

SomaLogic recently announced an agreement with the biopharmaceutical company Amgen that aims to advance Amgen's drug discovery and development programs through comprehensive proteomic profiling. We spoke with Roy Smythe to discover what barriers have been holding proteome analysis back, and how the collaboration with Amgen aims to change the landscape of drug discovery.
Biomaterial-Based Vaccine That Sits Under the Skin Shows Promise Against SARS-CoV-2
Industry Insight

Biomaterial-Based Vaccine That Sits Under the Skin Shows Promise Against SARS-CoV-2

A team of multidisciplinary scientists – including bioengineers, materials-scientists and immunologists – at the Wyss Institute has created a novel infection vaccine platform know as OmniVax. Technology Networks spoke with Lead Senior Staff Scientist Ed Doherty from the Wyss Institute for Biologically Inspired Engineering at Harvard University, to learn more.

Advertisement